2 small studies find a clue in the quest to help diagnose CTE in the
living
[November 20, 2026]
By LAURAN NEERGAARD
WASHINGTON (AP) — Scientists stumbled onto a hint that measuring a toxic
protein tied to Alzheimer’s disease just might one day be useful in
diagnosing a different brain disease in football players and others who
have suffered repeated blows to the head.
Doctors evaluate symptoms such as mood swings and memory loss to try to
tell if patients may have CTE, or chronic traumatic encephalopathy, a
disease linked to concussions and other brain trauma. But other diseases
cause similar symptoms, and a CTE diagnosis can only be confirmed by
examining the brain after death.
Now two small studies are highlighting a new clue — that a blood test
being developed to spot abnormal tau in the brains of Alzheimer’s
patients seems to also detect buildup of that protein in people with
advanced CTE.
Tau normally supports neurons but in Alzheimer’s, it tangles inside
those nerve cells. Scientists are developing a blood test to track those
tangles by detecting a particular tau fragment called eMTBR-tau243. But
researchers at Washington University in St. Louis got a surprise when
using autopsy records to study the new test – finding someone with high
levels of that biomarker who didn’t have Alzheimer’s but CTE instead.

The researchers turned to a larger collection of autopsied brain and
blood samples, eventually testing blood stored from 11 people classified
as having CTE.
Compared to samples stored from healthy people, levels of eMTBR-tau243
were higher in those with advanced CTE, said study co-author Chihiro
Sato, a WashU assistant neurology professor. That biomarker couldn’t
reliably identify early-stage CTE, the research team reported at a
dementia meeting in Japan last week.
[to top of second column]
|
 Separately, researchers at Boston
University and Arizona’s Banner Health were studying the same
question using blood stored from 21 former professional or school
football players who also donated their brain for research after
death. Autopsies found 16 died with advanced CTE, two with
earlier-stage CTE and three didn’t have the disease.
Blood levels of that tau biomarker were significantly higher in the
athletes with advanced CTE, the researchers reported Thursday at a
scientific meeting in Boston. Adding to the complexity, five of
those with CTE also had Alzheimer’s disease, resulting in the
highest levels of that tau biomarker.
Both studies were published in the medical journal JAMA.
The possible CTE link is interesting but very preliminary, requiring
much larger studies to see if there’s a real connection, cautioned
Northwestern University neuropathologist Dr. Rudolph Castellani, who
wasn’t involved with the research.
Abnormal tau is found in several additional brain diseases, which
can overlap in older adults. Moreover, tau buildup in CTE is
different from the type that occurs in Alzheimer’s, Drs. Günter
Höglinger and Carla Palleis of Germany’s Ludwig Maximilian
University of Munich wrote in an accompanying editorial in the
journal.
They also stressed the need for far more research, while saying the
two studies together “represent an important step” in the quest to
one day detect CTE in living patients.
All contents © copyright 2026 Associated Press. All rights reserved |